TRUPANION, INC. (TRUP) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current |
| Current obligations | 405.48M USD | Liabilities, Current |
| Cash and equivalents | 149.36M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Marketable Securities, Current |
| Customer receivables | (m) | |
| Inventory · excluded from quick assets | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $405.48M | $149.36M | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $408.37M | $153.46M | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $409.81M | $138.02M | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $390.77M | $154.77M | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $372.29M | $122.74M | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $369.34M | $166.31M | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $349.63M | $160.29M | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $361.85M | $137.48M | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $355.81M | $124.34M | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $351.58M | $146.46M | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $344.47M | $147.50M | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | $347.59M | $150.34M | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $330.66M | $118.42M | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $312.01M | $126.71M | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $289.62M | $65.61M | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $281.38M | $85.51M | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $260.19M | $101.61M | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $245.66M | $122.46M | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $223.70M | $87.40M | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $211.22M | $109.64M | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $189.86M | $117.33M | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $169.67M | $133.13M | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $150.40M | $139.88M | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | $139.85M | $35.23M | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | $117.98M | $30.01M | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | $103.65M | $27.22M | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $91.63M | $29.17M | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | $85.57M | $25.03M | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | $77.87M | $27.38M | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | $70.72M | $26.62M | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | $63.20M | $26.55M | (m) | (m) | (m) | (m) |
| 2018-09-30 | (m) | $61.23M | $34.68M | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | $57.13M | $95.42M | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | $51.90M | $30.79M | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $45.87M | $25.71M | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | $44.05M | $25.25M | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | $39.62M | $24.60M | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | $35.40M | $21.94M | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | $30.66M | $23.64M | (m) | (m) | (m) | (m) |
| 2016-09-30 | (m) | $27.46M | $20.63M | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | $25.25M | $18.21M | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | $23.63M | $17.53M | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | $23.62M | $17.96M | (m) | (m) | (m) | (m) |
| 2015-09-30 | (m) | $23.24M | $21.69M | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | $21.37M | $26.16M | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | $20.94M | $32.49M | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | $22.54M | $53.10M | (m) | (m) | (m) | (m) |
| 2014-09-30 | (m) | $21.28M | $59.07M | $19.30M | (m) | (m) | (m) |
| 2014-06-30 | (m) | $28.69M | $9.29M | $14.07M | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | $10.59M | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | $26.02M | $14.94M | $16.09M | (m) | (m) | (m) |
| 2013-09-30 | (m) | (m) | $5.28M | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | $5.07M | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | $4.23M | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | $8.09M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| Elevance Health, Inc. (ELV) | United States | $86.364B | 16.90 |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |